Cutaneous T-Cell Lymphoma (CTCL) Completed Phase 1 Trials for Resminostat (DB12392)

Also known as: Cutaneous T Cell Lymphoma (CTCL) / Cutaneous T Cell Lymphomas (CTCL) / Cutaneous T-Cell Lymphoma / Cutaneous T Cell Lymphoma / Cutaneous T-Cell Lymphomas / CTCL / Primary cutaneous T-cell lymphoma (morphologic abnormality) / Cutaneous T-cell lymphoma (morphologic abnormality) / Primary cutaneous T-cell lymphoma (disorder) / Lymphoma, T-Cell, Cutaneous

IndicationStatusPhase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04955340A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-ResminostatTreatment